Mark Stenhouse

Mark Stenhouse discloses dealings in 3 companies, chiefly Exact Sciences Corp, Prometheus Biosciences, Inc. and Phathom Pharmaceuticals, Inc. In total, 15 filings cover trades dated from 2 April 2019 to 3 June 2025.

On the open market, the record shows 1 purchase worth €223k and 3 sales worth €1.6M. Taken together, the sales exceed the purchases by €1.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants and 3 option exercises.

The newest entry dates from 5 June 2025: a share grant, in Phathom Pharmaceuticals, Inc. The clock since the last published purchase (16 March 2021) now reads 2,047 days. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.